Rearrangement of anaplastic lymphoma kinase (ALK) gene is the best predictor of response to crizotinib, an ALK tyrosine kinase inhibitor. However, the prevalence of the ALK fusion is low, so accurate patient identification is crucial for successful treatment using ALK inhibitors. Furthermore, most patients with lung cancer present with advanced-stage disease at the time of diagnosis, so it is important for pathologists to detect ALK-rearranged patients while effectively maximizing small biopsy or cytology specimens. In this review, we propose a guideline recommendation for ALK testing approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists.

Citations

Citations to this article as recorded by  

• Molecular Characteristics of Radon Associated Lung Cancer Highlights MET Alterations
  Gabriele Gamerith, Marcel Kloppenburg, Finn Mildner, Arno Amann, Sabine Merkelbach-Bruse, Carina Heydt, Janna Siemanowski, Reinhard Buettner, Michael Fiegl, Claudia Manzl, Georg Pall
  Cancers.2022; 14(20): 5113.     CrossRef
• ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
  Minsun Jung, Kyung Chul Moon, Jeongmo Bae, Tae Min Kim, Miso Kim, Yoon Kyung Jeon, Cheol Lee
  Archives of Pathology & Laboratory Medicine.2022; 146(12): 1460.     CrossRef
• Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
  Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
  Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
• Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
  Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan, Yoon-La Choi
  OncoTargets and Therapy.2021; Volume 14: 4671.     CrossRef
• Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society
  Pathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, Chong Kin Liam, Muhammad Azrif Ahmad Annuar, Norhayati Omar, Noriah Othman, Nurhayati Mohd Marzuki, Yong Kek Pang, Ros Suzanna Ahmad Bustamam, Lye Mun Tho
  Lung Cancer.2019; 136: 65.     CrossRef
• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
  Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H. Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benj
  Journal of Thoracic Oncology.2018; 13(3): 323.     CrossRef
• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
  Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H. Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benj
  The Journal of Molecular Diagnostics.2018; 20(2): 129.     CrossRef
• Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the
  Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric H Bernicker, Carol Colasacco, Sanja Dacic, Fred R. Hirsch, Keith Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette Sholl, Robyn Temple-Smolkin, Benja
  Archives of Pathology & Laboratory Medicine.2018; 142(3): 321.     CrossRef
• 5′/ 3′ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer
  Yongqing Tong, Zhijun Zhao, Bei Liu, Anyu Bao, Hongyun Zheng, Jian Gu, Mary McGrath, Ying Xia, Bihua Tan, Chunhua Song, Yan Li
  Journal of Experimental & Clinical Cancer Research.2018;[Epub]     CrossRef
• Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study
  Dae Ho Lee, Ming-Sound Tsao, Karl-Otto Kambartel, Hiroshi Isobe, Ming-Shyan Huang, Carlos H. Barrios, Adnan Khattak, Filippo de Marinis, Smita Kothari, Ashwini Arunachalam, Xiting Cao, Thomas Burke, Amparo Valladares, Javier de Castro, Aamir Ahmad
  PLOS ONE.2018; 13(8): e0202865.     CrossRef
• Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
  Saška Brajkovic, Benjamin Pelz, Maria-Giuseppina Procopio, Anne-Laure Leblond, Grégoire Repond, Ariane Schaub-Clerigué, Diego G Dupouy, Alex Soltermann
  Diagnostic Pathology.2018;[Epub]     CrossRef
• Expanded Circulating Tumor Cells from a Patient with ALK- Positive Lung Cancer Present with EML4-ALK Rearrangement Along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study
  Zhuo Zhang, Hiroe Shiratsuchi, Nallasivam Palanisamy, Sunitha Nagrath, Nithya Ramnath
  Journal of Thoracic Oncology.2017; 12(2): 397.     CrossRef
• Molecular Testing of Lung Cancers
  Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee
  Journal of Pathology and Translational Medicine.2017; 51(3): 242.     CrossRef
• Novel ALK fusion partners in lung cancer
  Aglaya G. Iyevleva, Grigory A. Raskin, Vladislav I. Tiurin, Anna P. Sokolenko, Natalia V. Mitiushkina, Svetlana N. Aleksakhina, Aigul R. Garifullina, Tatiana N. Strelkova, Valery O. Merkulov, Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, Kazimir M. Pozha
  Cancer Letters.2015; 362(1): 116.     CrossRef
• Strategic management of transthoracic needle aspirates for histological subtyping and EGFR testing in patients with peripheral lung cancer: An institutional experience
  Choonhee Son, Eun‐Ju Kang, Mee Sook Roh
  Diagnostic Cytopathology.2015; 43(7): 532.     CrossRef
• Current and future molecular diagnostics in non-small-cell lung cancer
  Chun Man Li, Wing Ying Chu, Di Lun Wong, Hin Fung Tsang, Nancy Bo Yin Tsui, Charles Ming Lok Chan, Vivian Wei Wen Xue, Parco Ming Fai Siu, Benjamin Yat Ming Yung, Lawrence Wing Chi Chan, Sze Chuen Cesar Wong
  Expert Review of Molecular Diagnostics.2015; 15(8): 1061.     CrossRef
• Role of biopsy sampling for diagnosis of early and progressed hepatocellular carcinoma
  Haeryoung Kim, Young Nyun Park
  Best Practice & Research Clinical Gastroenterology.2014; 28(5): 813.     CrossRef
• Molecular Pathology of Lung Cancer: Current Status and Future Directions
  Mee Sook Roh
  Tuberculosis and Respiratory Diseases.2014; 77(2): 49.     CrossRef
• Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity
  Sung-Jun Ko, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Jin-Haeng Chung, Tae Jung Kim, Kyung Won Lee, Kwhanmien Kim, Sanghoon Jheon, Hyojin Kim, Jae Ho Lee, Choon-Taek Lee
  BMC Cancer.2014;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Association Study of Pleural Mesothelioma and Oncogenic Simian Virus 40 in the Crocidolite-Contaminated Area of Dayao County, Yunnan Province, Southwest China
  Ru-ai Liu, Bo-yong Wang, Xin Chen, Yuan-qian Pu, Jia-ji Zi, Wen Mei, Ye-pin Zhang, Lu Qiu, Wei Xiong
  Genetic Testing and Molecular Biomarkers.2024;[Epub]     CrossRef
• Binding of SV40’s Viral Capsid Protein VP1 to Its Glycosphingolipid Receptor GM1 Induces Negative Membrane Curvature: A Molecular Dynamics Study
  Raisa Kociurzynski, Sophie D. Beck, Jean-Baptiste Bouhon, Winfried Römer, Volker Knecht
  Langmuir.2019; 35(9): 3534.     CrossRef
• Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033
  Kyeong Min Kwak, Domyung Paek, Seung-sik Hwang, Young-Su Ju, Mark Allen Pershouse
  PLOS ONE.2017; 12(8): e0183404.     CrossRef
• The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms
  Leonardo Vinícius Monteiro de Assis, Mauro César Isoldi
  Tumor Biology.2014; 35(2): 889.     CrossRef
• The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma
  Leonardo Vinícius Monteiro de Assis, Jamille Locatelli, Mauro César Isoldi
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2014; 1845(2): 232.     CrossRef
• Pleural Mesothelioma: An Institutional Experience of 66 Cases
  Soomin Ahn, In Ho Choi, Joungho Han, Jhingook Kim, Myung-Ju Ahn
  Korean Journal of Pathology.2014; 48(2): 91.     CrossRef

Perineuriomas are composed of differentiated perineurial cells. Perineuriomas have been recently recognized by the immunoreactivity for epithelial membrane antigen (EMA). Microscopically, perineuriomas show proliferation of spindle cells with wavy nuclei and delicate elongated bipolar cytoplasmic processes. The tumor cells are usually negative for the S-100 protein. Ultrastructurally, perineurial cells reveal slender, nontapered processes containing pinocytic vesicles and discontinuous basal lamina. Interestingly, hybrid tumors of benign peripheral nerve sheath tumor (PNST) have been recently reported by using immunohistochemical and ultrastructural investigations. Herein, we report a case of soft tissue perineurioma arising in the skin of a 56-year-old female; another case of a hybrid tumor of perineurioma and schwannoma in the posterior mediastinum occurred in a 53-year-old male, which is the first case of the hybrid PNST tumor reported in Korea.

Citations

Citations to this article as recorded by  

• Neurogenic tumours of the posterior mediastinum and differential diagnosis considerations
  Michael A den Bakker, Annikka Weissferdt
  Histopathology.2024; 84(1): 238.     CrossRef
• Hybrid tumors with perineurioma components: a systematic review of the literature and illustrative case
  Karina A. Lenartowicz, Dileep D. Monie, Kimberly K. Amrami, Christopher J. Klein, Caterina Giannini, Robert J. Spinner
  Acta Neurochirurgica.2022; 165(4): 935.     CrossRef
• Hybrid Schwannoma/Perineurioma: Morphologic Variations and Genetic Profiles
  Takanori Hirose, Anna Kobayashi, Sumihito Nobusawa, Naoe Jimbo
  Applied Immunohistochemistry & Molecular Morphology.2021; 29(6): 433.     CrossRef
• Mesenchymal Tumors of the Mediastinum: An Update on Diagnostic Approach
  Joon Hyuk Choi, Jae Y. Ro
  Advances in Anatomic Pathology.2021; 28(5): 351.     CrossRef
• Neurogenic Tumors of the Mediastinum
  Erika F. Rodriguez, Robert Jones, Daniel Miller, Fausto J. Rodriguez
  Seminars in Diagnostic Pathology.2020; 37(4): 179.     CrossRef
• A Rare Perineurioma/Granular Cell Tumor Hybrid Peripheral Nerve Sheath Tumor
  Koorosh Haghayeghi, Gladys Telang, Sonja Chen, Jack Bevivino, Shamlal Mangray, Yiang Hui, Leslie Robinson-Bostom
  The American Journal of Dermatopathology.2020; 42(10): 762.     CrossRef
• Hybrid peripheral nerve sheath tumors
  Emine KILIÇ BAĞIR, Arbil AÇIKALIN, Gülfiliz GÖNLÜŞEN, Suzan ZORLUDEMİR, Mehmet Ali DEVECİ
  Cukurova Medical Journal.2019; 44(3): 804.     CrossRef
• Primary intraosseous hybrid epithelioid schwannoma/perineurioma in the proximal tibia: a case report of benign hybrid neoplasm with local hypercellularity
  Yuejiao Lang, Dawei Liu, Pei Xiang, Jilin Wang, Yang Li
  Diagnostic Pathology.2019;[Epub]     CrossRef
• Hybrid peripheral nerve sheath tumors: report of five cases and detailed review of literature
  Nasir Ud Din, Zubair Ahmad, Jamshid Abdul-Ghafar, Rashida Ahmed
  BMC Cancer.2017;[Epub]     CrossRef
• Primary intraosseous hybrid nerve sheath tumor of femur: A hitherto undescribed occurrence in bone with secondary aneurysmal bone cyst formation resulting in pathological fracture
  Louis Tsun Cheung Chow
  Pathology - Research and Practice.2015; 211(5): 409.     CrossRef
• Mesenchymal tumours of the mediastinum—part II
  Michael A. den Bakker, Alexander Marx, Kiyoshi Mukai, Philipp Ströbel
  Virchows Archiv.2015; 467(5): 501.     CrossRef
• Primary pleural hybrid cellular schwannoma/perineurioma: A case report
  Danny Soria-Céspedes, Carlos Robles-Vidal, Arturo Gómez-González, Rosalinda Peñaloza-Ramírez, Carlos Ortiz-Hidalgo
  Respiratory Investigation.2014; 52(4): 269.     CrossRef
• Hybrid peripheral nerve sheath tumour with intermingled perineuriomatous and schwannomatous areas reflected in skin ultrasonography image
  H. Saeki, K. Ito, Y. Nobeyama, T. Ishiji, M. Fukunaga, H. Nakagawa
  Clinical and Experimental Dermatology.2014; 39(6): 747.     CrossRef
• Périneuriome extraneural des tissus mous localisé au nez
  A. Zaouak, R. Benmously, M. Belhadj Salah, W. Koubaa, A. Debbiche, I. Mokhtar
  Annales de Dermatologie et de Vénéréologie.2013; 140(8-9): 540.     CrossRef